A201(VI)- Various cancer tissues

Similar documents
A301 VI- Various cancer tissues with corresponding normal tissues

A103(9)- Normal tissues, more than single spots

(formalin fixed) 6 non-neoplastic spots (6 spots) Corresponding normal tissues with cancers: Yes Diameter: 1. 0 mm

A218 : Esophagus cancer tissues. (formalin fixed)

A916: rectum: adenocarcinoma

A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues

A215- Urinary bladder cancer tissues

A220: Larynx cancer tissues. (formalin fixed)

Gastric Cancer Histopathology Reporting Proforma

Definition of Synoptic Reporting

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Quiz. b. 4 High grade c. 9 Unknown

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

MT09 - Normal Human Tissue Microarray, FDA

SHN-1 Human Digestive Panel Test results

MALIGNANT NEOPLASMS OF THE BREAST MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS

NAACCR Webinar Series 1 Q&A. Fabulous Prizes. Collecting Cancer Data: Ovary 11/3/2011. Collecting Cancer Data: Ovary

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005

Peritoneum: Def. : It is a thin serous membrane that lines the walls of the abdominal and pelvic cavities and clothes the viscera.

Index. Note: Page numbers of article titles are in boldface type.

Staging and Treatment Update for Gynecologic Malignancies

UICC TNM 8 th Edition Errata

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release

Histology Coding ANSWERS

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:

UICC TNM 8 th Edition Errata

Carcinoma of the Urinary Bladder Histopathology

In the name ofgod. Abdomen 3. Dr. Zahiri

Case Scenario 1: Thyroid

Radiology Pathology Conference

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung

Thyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary

Radiology Pathology Conference

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

Comprehensive Cancer Cover

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green

Quiz The main functions of the ovaries are a. To produce oocytes b. To produce estrogen c. To produce progesterone d.

Summary Stage 2018 (SS2018)

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98

UICC 8 th Edition Errata 25 th of May 2018

Cancer Association of South Africa (CANSA)

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

Endometrial Stromal Sarcoma

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

Neoplasia literally means "new growth.

Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?

DUSTURBANCES OF GROWTH. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L8 Uz: Musa

*OPERATIVE PROCEDURE. Serum tumour markers within normal limits S1.04 PRINCIPAL CLINICIAN

Staging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

2018 Implementation: SEER Summary Stage 2018

Melanoma Case Scenario 1

3 Circulatory Pathways

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL

AJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY-

CEA (CARCINOEMBRYONIC ANTIGEN)

Anatomical Considerations for Lab Practical II

Epithelial tumors. Dr. F.F. Khuzin, PhD Dr. M.O. Mavlikeev

Cancer Program Report 2014

END-SEMESTER EXAM 2018 ANATOMY, HISTOLOGY AND EMBRYOLOGY FACULTY OF MEDICINE, 2 ND SEMESTER

Melanoma Case Scenario 1

Case Report Tumor-to-Tumor Metastasis: Lung Carcinoma Metastasizing to Thyroid Neoplasms

NEOPLASIA-I CANCER. Nam Deuk Kim, Ph.D.

FINALIZED SEER SINQ QUESTIONS

Date Lab Pd. Lecture Notes (57)

Cancer in Estonia 2014

Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies

Neuroendocrine Carcinoma. Lebanon Neuroendocrine Neoplasms of H&N Nov /7/2011. Broad Classification:

Thyroid and Adrenal Gland

Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult

Multi-normal human tissues, FDA, 96 samples, 35 organs/sites from three individuals (1.5mm)

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent.

ACTIVITY 11: RESPIRATORY AND DIGESTIVE SYSTEMS RESPIRATORY SYSTEM

MICROSTRUCTURES SMALL INTESTIN LARGE INTESTIN PANCREAS LIVER GALLBLADDER SALIVARY GLANDS ADRENALS THYROID AND PARATHYROID GLANDS

study of body structure & Physiology study of body function

OFCCR CLINICAL DIAGNOSIS AND TREATMENT FORM

The Lymphoid System Pearson Education, Inc.

AJCC 7th Edition Handbook Errata as of 9/21/10

Esophageal Cancer Staging Essentials: The New TNM Staging System (7th edition) and Clinicoradiologic Implications

What is endometrial cancer?

General history. Basic Data : Age :62y/o Date of admitted: Married status : Married

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

PRIMARY ADENOCARCINOMA OF THE FALLOPIAN TUBE - A CASE REPORT

Transcription:

A201(VI)- Various cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 44 Tissue type: Various cancer tissues No. of spots: 2 spots from each cancer case (88 spots) Total spots: 88 Corresponding normal tissues with cancers: Diameter: 1. 0 mm Documents: Product specification: layout, summary of tissue spots H&E stained images Detailed pathological information Layout: P-07-04-10T

A201(VI)- Various cancer tissues Summary of tissue spots (formalin fixed) For research use only P-07-04-11T

A201(VI)- Various cancer tissues Summary of tissue spots (formalin fixed) For research use only P-07-04-11T

A201(VI)- Various cancer tissues (formalin fixed) For research use only QC sheet_lot#122121008011 Hematoxylin and Eosin staining A1 A2 A3 A4 A5 A6 A7 A8 A9 A10 A11 A12 B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 B11 B12 P-07-04-12T

A201(VI)- Various cancer tissues (formalin fixed) For research use only QC sheet_lot#122121008011 Hematoxylin and Eosin staining C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 D1 D2 D3 D4 D5 D6 D7 D8 D9 D10 D11 D12 P-07-04-12T

A201(VI)- Various cancer tissues (formalin fixed) For research use only QC sheet_lot#122121008011 Hematoxylin and Eosin staining E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 E11 E12 F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 P-07-04-12T

A201(VI)- Various cancer tissues (formalin fixed) For research use only QC sheet_lot#122121008011 Hematoxylin and Eosin staining G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12 H1 H2 H3 H4 P-07-04-12T

1 1,2 f 40 brain: anaplastic astrocytoma Cerebral mass, left thalamus, Removal of tumor(fs): Glioblastoma. 2 3,4 m 8 brain: choroid plexus papillomabrain, intraventricular,left,removal: choroid plexus papilloma 3 5,6 m 64 A 4 7,8 f 66 5 9,10 m 71 6 11,12 m 37 esophagus : squamous cell esophagus :squamous cell larynx : squamous cell thymus:atypical carcinoid Esophagus and cardia of stomach, esophagectomy and node dissection: 1.Ulcerative squamous cell, poorly differentiated, 1) size: 3.3x1cm 2) extension to the outer muscle layer 3) lymphovascular permeation: Positive 2.Resection margins, proximal and distal: Free of tumor. 3.Regional lymph nodes: Free of tumor in all nodes(0/24), in detail, subcarinal(0/10), hilar(0/2), pretracheal(0/6),lower paratracheal(0/3), left paracardial(0/2), 8L(0/1),omental mass(free of tumor). Esophagus, resection: 1.Invasive squamous cell, moderately differentiated 1) size: 6x2.5cm 2) infiltrative growth 3) extension through the muscle layer to the adventitia but intact lateral resection margin 4) perineural and vascular invasion 5) resection margins, proximal and distal(stomach): Free of tumor. 6) regional lymph nodes:free of tumor in all 24 lymph(0/24),indetail,ipl(0/1),subcarinal(0/1),paraesophageal (0/5), pyloric(0/3), left hilar(0/5), celiac(0/1),right recurrent laryngeal(0/3), greater curvature(0/2), left ardial(0/3). larynx: squamous cell Thymus thymectomy: 1.Atypical carcinoid showing vascular invasion,penetrating the capsule 1) invassion into the thymic fat tissue and multifocal necrosis. *Note: immunohistochemical staining results ACTH, Synaptophysin,Chromogranin NSE:positive

7 1,2 m 52 8 3,4 f 46 9 5,6 m 43 10 7,8 f 53 thyroid gland:papillary cacinoma thyroid gland:papillary cacinoma thyroid gland:papillary cacinoma thyroid gland : papillary Thyroid gland, total thyroidectomy with neck node dissection: 1.Papillary 1) involving bilateral whole lobe(size: 6.5x3.7cm) 2) extension to perithyroidal fat tissue 2. Regional lymph node: Tumor metastasis to 4 out of 20(4/20), in detail, level II(1/2), level III(3/13), level IV(0/5). Thyroid, total thyroidectomy:papillary 1) size: 4.5x3x2.5cm 2) extensive extension to perithyroidal soft tissue and surrounding skeletal muscle. 3) lymphovascular invasion. 4) multiple metastasis to surrounding soft tissue and lymph nodes (29/62: level 2,3,4,5(12/35), level 2(2/10),No.6(1/1), perithyroidal(14/16)). 5) intact jugular vein. 6) nodular goiter Thyroid gland, right, thyroidectomy: Papillary with extension beyond thyroid capsule. Thyroid gland, site unstated, thyroidectomy: Papillary extending beyond extrathyroidal tissue, in the background of Hashimoto's thyroiditis. B 11 9,10 f 57 breast: infiltrating ductal Breast, left, palliative mastectomy: 1.Infiltrating ductal 1) Histologic grade: II. 2) Black's nuclear grade: I 3) Extensive lymphatic invasion. 4) Intraductal component: less than 10%. 5) Multinodularity. 2.Nipple and areola: Free of tumor. 3.Overlying skin: Superficial dermal invasion by the tumor. 4.nderlying fascia: Presence of tumor, focal. 5.Lymph nodes, level I(9/23) and level II(2/2): Metastasis in 11 out of 25 lymph nodes (pn1biv). 6. Result of immunohistochemical staining: ER(+), PR(-), C erb B2(-).

12 11,12 f 47 breast: infiltrating ductal Breast, left, modified radical mastectomy: 1.Infiltrating ductal 1) size: 8x7x2cm 2) Modified Bloom-Richardson's histological grade: II (moderately differentiated) (tubule formation: III, nuclear pleomorphism: II, mitosis: II) 3) Black's nuclear grade: 2(moderately differentiated) 4) extensive lymphovascular invasion 5) extension to the anterior(fibroadipose) margin. 2.Nipple and areola: Focal direct invasion to the subdermal layer. 3.Overlying skin: Free of tumor. 4.Underlying fascia: Tumor's involvement. 5.Regional lymph nodes: Metastatic in 3 out of 8 lymph nodes (3/8), in detail, level II(0/1), level III(0/1), axillary lymph nodes(3/6). 6.Result of immunohistochemical staining: ER(+), PR(-), C erb B2(+). 13 1,2 f 72 stomach : adeno Stomach, pancreas and spleen, radical total gastrectomy, splenectomy and pancreatectomy: 1.Stomach: Ulceroinfiltrative adeno, moderately differentiated, 1) size: 10.7x9cm 2) extension to the serosa and pancreas parenchyme 3) lymphovascular permeation: positive 4) Intestinal type by Lauren's classification 2. Resection margins, proximal and distal: Free of tumor. Resection margin, pancreas: Free of tumor. 3. Regional lymph nodes: Tumor metastasis to 2 out of 47(2/47), in detail, N1(0/5), N3(0/5), N4(0/8), N5(0/2), N6(1/16), N7(0/2), N8(1/4), N9(0/2), N10(0/3). 4. Pancreas: Tumor extension. 5. Spleen: Congestion.

14 3,4 f 73 stomach : adeno Stomach with omentums, total gastrectomy: 1.Polypoid and infiltrative adeno, well to poorly differentiated, in antrum and body 1) size: 12.5x10.5cm 2) mixed type (by Lauren classification) and infiltrative growth type (by Ming classification) 3) extension to outer proper muscle layer 4) frequent vascular and perineural invasions 5) metastasis to 23 out of 47 omental lymph nodes (No.3(11/16), No.4(2/6), No.5(2/2), No.7(2/7), No.8(0/1) and No.9(0/2)) 6) non-neoplastic mucosa showing multifocal atrophic gastritis with intestinal metaplasia. 15 5,6 f 56 soft tissue: fibromatosis Soft tissue, buttock, left, excision: Fibromatosis, extraabdominal. 16 C 7,8 f 73 soft tissue:ganlioneuroma Soft tissue, mediastinum, excision: Ganglioneuroma. 17 9,10 m 71 tongue: squamous cell Tongue, tonsil, salivary gland and regional lymph nodes, left hemiglossectomy and radical neck dissection: Invasive squamous cell, moderately differentiated 1) size: 6x4.3x3.5cm 2) infiltrative growth 3) extension to underlying skeletal muscle 4) intact anterior, posterior, lateral and medial resection margins 5) intact but very close to basal resection margin (safety resection margin: less than 1mm) 6) metastasis to 1 out of 49 regional lymph nodes (right level II(0/10), right level III(0/3), right level IV (0/13), left level II(1/8), left level III(0/0), left level IV(0/7), and left level V(0/8)) Salivary gland, submandibular: Free from tumor extension.

18 11,12 m 58 tongue: squamous cell Tongue and lymph node, wide excision and dissection: 1. Tongue: Squamous cell, well differentiated 1) size: 2.7x2.2cm 2) extension to the sublingual gland 3) perineural invasion(+) 2. Resection margins, anterior, posterior, lateral side and basal 1) margin: Free of tumor. 3. Salivary gland, submandibular: Free of tumor. 4. Skeletal muscle: Free of tumor. 5. Regional lymph nodes: Free of tumor in all nodes(0/53), in detail, right level IIb(0/10), right level IIa(0/8), right level III (0/2), right level IV(0/4), right level Ib(0/5), left level Ia (0/4), left level Ib(0/5), left level III(0/6), left level IIa (0/3), left level IIb(0/6). 19 1,2 m 77 lung: non-small cell Lung, right upper lobe, lobectomy: 1.Poorly differentiated, non-small cell type. 1) confined with the lung parenchyme and no visceral pleura involvement. 2) two separate masses (3.9x3.2cm and 2.6x2cm) with same histology. 3) lymphatic permeation: positive. 2.Resection margin, bronchial: Free of tumor. 3.Surrounding lung: Emphysema. 4.Regional lymph nodes: Tumor metastasis to 1 out of 37 (1/37),in detail, left hilar(0/2), subcarinal(0/13), lower paratracheal(0/2), hilar(0/3), peribronchial(0/4), IPL(0/2), regional, attached(1/11). 5.Results of histochemical and immunohistochemical staining: PAS(-), Mucicarmine(-), NSE(-), Synaptophysin(-), Chromogranin(-) Lung, right upper lobe, lobectomy: 1.Poorly differentiated, non-small cell type, probably adeno 1) confined within the lung parenchyme and no visceral pleura involvement 2) two completely separate masses (3.9x3.2cm and 2.6x2cm) with same histology (T4) 3) lymphatic permeation: Positive 2. Resection margin, bronchial: Tumor positive.

20 3,4 m 57 lung: adeno D 21 5,6 m 82 lung :squamous cell 22 7,8 f 64 lung :lage cell 23 9,10 f 76 24 11,12 m 71 lymph node: metastatic papillary lymph node: metastatic Lung, LLL, lobectomy: 1. Adeno, acinic and papillary 1) marked mucin production 2) size: 4.7x4.6cm 3) extension to visceral pleura 2. Bronchial resection margin: Free of tumor. 3. Regional lymph node, peribronchial: Tumor metastasis (1/1). Lung, LLL, lobectomy: 1. Squamous cell, poorly differentiated 1) size: 3.5x3cm 2) extension to the visceral pleura 2. Bronchial resection margin: Free of tumor. Lung, right lower lobe, lobectomy: 1) squamous cell, moderately differentiated - size: 7x5cm - extension to the visceral pleura - associated obstructive pneumonitis 2) bronchial resection margin: free of tumor. Lymph nodes, neck, right, internal jugular vein, upper (4/12) and lower(0/8), modified radical neck dissection: Metastatic papillary of the thyroid gland in 4 out of 20 nodes. Lymph nodes and submandibular gland, left, radical neck dissection: 1. Lymph nodes, level I(3/5), level IIa(1/2), level IIb(0/7), level III(0/2), level IV(4/7) and level V(1/4):(9/37): Metastatic poorly differentiated. 2. Submandibular gland: Free of tumor. 3. Oral mass, separately submitted: Involvement of. 4. Immunohistochemical stain results: Cytokeratin: positive, NSE, Synaptophysin, Chromogranin, CD56, leukocyte common antigen: negative.

25 1,2 m 76 liver :cholangio 26 3,4 m 70 liver :metatstatic 27 5,6 m 60 liver :hepatocellular Liver, right lobe, lobectomy: 1. Cholangio, moderately differentiated, peripheral type 1) size: 11.5x9.5x7.0cm 2) expanding growth and extensive necrosis 3) penetration of hepatic capsule and invasion to soft tissue adjacent to diaphragm 4) vascular invasion (but not portal vein) 5) intrahepatic metastasis 6) intact intrahepatic resection margin and diaphragm 7) nonneoplastic liver showing reactive hepatitis 2. Gallbladder, cholecystectomy: Free from tumor extension. Liver, right lobe, lobectomy: Metastatic, multiple, originated from large cell undifferentiated of lung(s2004-5976) 1) size: 5.7x5.5x4.3cm and 4.0x3.5x3.5cm 2) frequent vascular invasion 3) intact intrahepatic resection margin 4) nonneoplastic liver showing reactive hepatitis Liver, right lobe, lobectomy: Hepatocellular 1) size: 8x8x6.8cm 2) Edmondson-Steiner grade III 3) clear cell(majority) and trabecular histologic type 4) single nodular type with perinodal spreading growth 5) necrosis: less than 10% of total volume 6) microvascular invasion 7) intact intrahepatic resection margin 8) nonneoplastic liver showing: Chronic hepatitis, B viral, with mild inflammatory activity (Grade II) and early cirrhosis(stage III).

E 28 7,8 f 66 liver :hepatocellular Liver, right lobe, lobectomy: 1. Hepatocellular 1) size: 10.5x7.4x5cm 2) mixed histologic patterns including trabecular, adenoid and clear cel types 3) Edmondson grade II+III 4) single nodular type with perinodal spread 5) expanding but focal infiltrating growth pattern 6) microvascular invasion 7) no significant necrosis(less than 20% of total volume) 8) resection margin: Free of tumor. 2. Gallbladder, cholecystectomy: Autolytic changes. <Additional report > nonneoplastic liver: Chronic hepatitis, B-viral, with minimal inflammatory activity(grade I) and septal fibrosis(stage III). 29 9,10 m 53 kidney :renal cell Kidney, left, nephrectomy: 1. Renal cell, clear cell type 1) size: 4x4cm 2) confined within the renal capsule 3) nuclear grade II 2. Renal artery and vein: Free of tumor. 3. Ureter resection margin: Free of tumor. 4. Adrenal gland: Free of tumor.

30 11,12 f 71 31 1,2 f 23 32 3,4 f 54 kidney :renal cell ovary :malignant germ cell tumor ovary :serous cystadeno 33 5,6 f 44 ovary :clear cell Adrenal gland and kidney, left, radical adrenalectomy and nephrectomy: 1. Adrenal gland: Adrenal cortical, 1) size: 12x10cm 2) extension to the capsule and adjacent pancreas 2. Kidney: Free of tumor. 3. Ureter: Free of tumor. 4. Separate mass: Adrenal cortical, 5. Regional lymph node: Tumor metastasis(5/6), in detail, retroperitoneal(4/4), splenic(1/2) 6. Retroperitoneal resection margin: Free of tumor. 7.Spleen, splenectomy: Free of tumor. Ovary and fallopian tube, right, right salpingooophorectomy: 1.Ovary: Malignant germ cell tumor, probably yolk sac tumor (endodermal sinus tumor). 2. Fallopian tube: Paraovarian cyst. 3. Result of special stain: AFP(+), HCG(-), PAS(+), D-PAS(-). Uterus with right adnexa, total abdominal hysterectomy with right salpingooophorectomy: 1. Cervix: Chronic nonspecific inflammation. 2. Endometrium: Secretory phase. 3. Myometrium : 1) Leiomyomas, intramural. 2) Adenomyosis. 3) Tumor involvement at the outer wall of myometrium. 4.Ovary, right: Serous cystadeno. 5.Fallopian tube: Tumor involvement at the serosa wall. 6.Lymph nodes: Tumor metastasis to 4 out of 8(4/8), in detail, right pelvic(1/4), left pelvic(3/4). 7.Mass of right infundibulopelvic ligament: Tumor involvement. 8.Omentum: Free of tumor. Ovary, right, right salpingoophorectomy: Clear cell adeno, well differentiated, with extraovarian spread. Fallopian tube: Free of tumor.

34 7,8 f 33 ovary : mucinous cystadeno Ovary and fallopian tube, left, salpingooophorectomy: Ovary: Mucinous cystadeno confined within the capsule. Fallopian tube: Free of tumor. Ovary, right, partial oophorectomy: Mesothelial hyperplasia without tumor. Soft tissue, right and left, paracolic gutter, right retroperitoneum: Chronic nonspecific inflammation without tumor. Omentum, partial omentectomy: Chroni nonspecific inflammation with mesothelial hyperplasia. F 35 9,10 f 68 uterine cervix:squamous cell Uterus with both adnexae, radical abdominal hysterectomy with bilateral salpingooophorectomy, BPLND: 1) cervix: Invasive squamous cell, moderately differentiated - large cell, keratinizing - size: 3.3x3cm - extension to the nearly whole depth(invasion depth: 1.7cm) - lateral margin: Free of tumor - lymphovascular permeation: positive 2) endometrium: atrophy 3) myometrium : leiomyoma, subserosal 4) ovaries, bilateral: no pathological diagnosis 5) fallopian tubes, bilateral: no pathological diagnosis 6) parametrium, bilateral: free of tumor 7) vaginal cuff: free of tumor 8) regional lymph nodes: free of tumor in all nodes(0/16), in detail, right pelvic node(0/9), left pelvic node(0/5), common iliac node(0/2).

36 11,12 f 58 uterine cervix: invasive squamous cell Uterus with both adnexae, radical abdominal hysterectomy with bilateral salpingooophorectomy: 1.Cervix: Invasive squamous cell, large cell partly keratinizing 1) size: 3.2x3.8cm 2) entire cervix and lower endometrium involvement 3) extension through the whole depth (2.2cm in depth), but lateral margin, free of tumor. 4) ymphovascular permeation, suspicious 2.Endometrium: Atrophy. 3.Myometrium: Leiomyoma, intramural. 4.Ovaries, bilateral: No pathological diagnosis. 5.Fallopian tubes, bilateral: No pathological diagnosis. 6.Parametrium, bilateral: Free of tumor. 7.Vaginal cuff: Free of tumor. 8. Regional lymph nodes: Free of tumor in all nodes (0/20), in detail, right pelvic node(0/10), left pelvic node(0/10). 37 1,2 m 32 testis:seminoma 38 3,4 m 38 tests:seminoma Testis, pelvic, orchiectomy: Seminoma, classic, with multifocal necrosis and extensive vascular invasion. Spermatic cord: No pathological Testis, left, orchiectomy: Seminoma with invasion beyond tunica albuginea (pt2) and associated with intratubular germ cell neoplasia. Spermatic cord: Free of tumor.

39 5,6 m 74 colon :adeno Colon, sigmoid, radical sigmoid colectomy: 1. Ulcero-fungating adeno, poorly differentiated 1) size: 4.2cm in length 2) extension to the pericolic fat tissue (pt3c) 3) lateral margin: Free of tumor. 4) lymphovascular permeation: present 2. Resection margins, proximal and distal: Free of tumor. 3. Regional lymph nodes: Tumor metastasis to 2 out of 17(2/17), in detail, principal(0/8), regional(2/9). MSI(Microsatellite instability) test Marker Name bat26 D5S346 bat25 D17S250 D2S123 판독 Microsatellite No No No No No MSS instability Allelic uninformative uninformative No(1.15) uninformative Imbalance 40 7,8 m 47 G colon :adeno Colon, rectum, lower anterior resection: 1. Colon: Ulcerofungating adeno, moderately differentiated, 1) size: 5.5x4.5cm 2) extension to the pericolic fat tissue(pt3c) 3) lateral margin: Free of tumor 4) lymphovascular permeation: Positive 2. Urinary bladder: Free of tumor. 3. Resection margins, proximal and distal: Free of tumor. 4. Regional lymph nodes: Tumor metastasis to 4 out of 11(4/11), in detail, regional(4/8), principal(0/3).

41 9,10 m 46 rectum :adeno Rectum, low anterior resection: Ulcerofungating adeno, moderately differentiated 1) size: 6.2x5.2cm 2) infiltrative growth 3) extension to perirectal soft tissue but intact lateral resection margin 4) no vascular and perineural invasion 5) intact proximal and distal resection margins 6) metastasis to 5 out of 29 perirectal lymph nodes (principal(0/9) and perirectal(5/20)) MSI(Microsatellite instability) test Marker Name bat26 D5S346 bat25 D17S250 D2S123 판독 Microsatellite No No No No No MSS instability 42 11,12 f 79 rectum :adeno Allelic uninformative uninformative No(0.79) No(1.28) Imbalance Rectum, low anterior resection: 1. Ulcerative adeno, moderately differentiated, 1) size: 3.5x3.7cm 2) extension to the outer muscle layer(pt2) 3) lymphovascular permeation, positive 4) lateral margin: Free of tumor 2. Resection margins, proximal and distal: Free of tumor. 3. Separate mass at distal resection margin: Adenoma with low grade dysplasia. 4. Regional lymph nodes: Tumor metastasis to 1 out of 11(1/11), in detail, principal(0/2), regional(1/9). ** MSI(Microsatellite instability) test Marker Name bat26 D5S346 bat25 D17S250 D2S123 판독 Microsatellite No No No No No MSS instability Allelic uninformative No(0.86) uninformative No(0.97) No(0.88) Imbalance

Skin, lower back, wide excision: 43 1,2 m 55 skin :dermatofibrosarcoma Dermatofibrosarcoma protuberans. Resection margin: Free of tumor. H 44 3,4 m 40 skin : squamous cell Skin, scalp, excision: Invasive squamous cell, well-differentiated with 1) extension to the subcutaneous fat tissue (invasion depth: about 3cm). Resection margins, all circumference and base: Free of tumor. Lymph nodes, level 2a(0/36), level 2b(0/11), level III(0/25), level IV(0/13) and level V(0/11):(0/96): Free of tumor.